UBS Group’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
167,865
+115,621
| +221% | +$244K | ﹤0.01% | 5102 |
|
|
2025
Q1 | $63.7K | Buy |
52,244
+464
| +0.9% | +$566 | ﹤0.01% | 6114 |
|
|
2024
Q4 | $66.8K | Buy |
51,780
+37,448
| +261% | +$48.3K | ﹤0.01% | 5897 |
|
|
2024
Q3 | $39.4K | Buy |
14,332
+1,125
| +9% | +$3.09K | ﹤0.01% | 5771 |
|
|
2024
Q2 | $29.8K | Buy |
+13,207
| New | +$29.8K | ﹤0.01% | 5909 |
|
|
2024
Q1 | – | Sell |
-622
| Closed | -$1.03K | – | 8294 |
|
|
2023
Q4 | $1.03K | Buy |
+622
| New | +$1.03K | ﹤0.01% | 7210 |
|
|
2023
Q1 | – | Sell |
-5,561
| Closed | -$6.28K | – | 8654 |
|
|
2022
Q4 | $6.28K | Buy |
+5,561
| New | +$6.28K | ﹤0.01% | 7862 |
|
|
2022
Q3 | – | Sell |
-1,776
| Closed | -$2K | – | 9374 |
|
|
2022
Q2 | $2K | Buy |
+1,776
| New | +$2K | ﹤0.01% | 8509 |
|
|
2021
Q4 | – | Sell |
-1,988
| Closed | -$8K | – | 9203 |
|
|
2021
Q3 | $8K | Buy |
1,988
+988
| +99% | +$3.98K | ﹤0.01% | 7047 |
|
|
2021
Q2 | $3K | Sell |
1,000
-5,454
| -85% | -$16.4K | ﹤0.01% | 7691 |
|
|
2021
Q1 | $14K | Sell |
6,454
-17,114
| -73% | -$37.1K | ﹤0.01% | 6648 |
|
|
2020
Q4 | $53K | Buy |
23,568
+20,572
| +687% | +$46.3K | ﹤0.01% | 5140 |
|
|
2020
Q3 | $8K | Sell |
2,996
-9,405
| -76% | -$25.1K | ﹤0.01% | 6129 |
|
|
2020
Q2 | $38K | Sell |
12,401
-12,608
| -50% | -$38.6K | ﹤0.01% | 5255 |
|
|
2020
Q1 | $49K | Sell |
25,009
-26,310
| -51% | -$51.5K | ﹤0.01% | 4961 |
|
|
2019
Q4 | $147K | Buy |
51,319
+17,891
| +54% | +$51.2K | ﹤0.01% | 4777 |
|
|
2019
Q3 | $123K | Buy |
33,428
+15,348
| +85% | +$56.5K | ﹤0.01% | 4716 |
|
|
2019
Q2 | $75K | Buy |
18,080
+11,356
| +169% | +$47.1K | ﹤0.01% | 4748 |
|
|
2019
Q1 | $34K | Sell |
6,724
-2,382
| -26% | -$12K | ﹤0.01% | 5015 |
|
|
2018
Q4 | $31K | Buy |
9,106
+7,151
| +366% | +$24.3K | ﹤0.01% | 5554 |
|
|
2018
Q3 | $12K | Sell |
1,955
-5,246
| -73% | -$32.2K | ﹤0.01% | 6146 |
|
|
2018
Q2 | $46K | Buy |
7,201
+1,079
| +18% | +$6.89K | ﹤0.01% | 5136 |
|
|
2018
Q1 | $29K | Buy |
+6,122
| New | +$29K | ﹤0.01% | 5249 |
|
|
2017
Q4 | – | Sell |
-6,643
| Closed | -$14K | – | 6889 |
|
|
2017
Q3 | $14K | Buy |
6,643
+4,230
| +175% | +$8.92K | ﹤0.01% | 5789 |
|
|
2017
Q2 | $6K | Sell |
2,413
-1,292
| -35% | -$3.21K | ﹤0.01% | 6099 |
|
|
2017
Q1 | $9K | Buy |
3,705
+2,864
| +341% | +$6.96K | ﹤0.01% | 5747 |
|
|
2016
Q4 | $1K | Buy |
+841
| New | +$1K | ﹤0.01% | 6621 |
|
|
2016
Q3 | – | Sell |
-5,936
| Closed | -$9K | – | 6744 |
|
|
2016
Q2 | $9K | Buy |
5,936
+5,846
| +6,496% | +$8.86K | ﹤0.01% | 5941 |
|
|
2016
Q1 | $0 | Hold |
90
| – | – | ﹤0.01% | 6756 |
|
|
2015
Q4 | $0 | Sell |
90
-2,867
| -97% | – | ﹤0.01% | 6915 |
|
|
2015
Q3 | $7K | Buy |
2,957
+845
| +40% | +$2K | ﹤0.01% | 6104 |
|
|
2015
Q2 | $6K | Buy |
2,112
+504
| +31% | +$1.43K | ﹤0.01% | 6214 |
|
|
2015
Q1 | $6K | Sell |
1,608
-1,906
| -54% | -$7.11K | ﹤0.01% | 6115 |
|
|
2014
Q4 | $12K | Buy |
+3,514
| New | +$12K | ﹤0.01% | 5897 |
|